Manisha Mone

4.2k total citations · 2 hit papers
29 papers, 2.7k citations indexed

About

Manisha Mone is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Manisha Mone has authored 29 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 10 papers in Molecular Biology and 10 papers in Genetics. Recurrent topics in Manisha Mone's work include Chronic Lymphocytic Leukemia Research (10 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Eosinophilic Disorders and Syndromes (7 papers). Manisha Mone is often cited by papers focused on Chronic Lymphocytic Leukemia Research (10 papers), Chronic Myeloid Leukemia Treatments (10 papers) and Eosinophilic Disorders and Syndromes (7 papers). Manisha Mone collaborates with scholars based in United States, Switzerland and France. Manisha Mone's co-authors include Brian Druker, François Guilhot, Andreas Hochhaus, John M. Goldman, Richard A. Larson, Timothy P. Hughes, Jerald P. Radich, Insa Gathmann, Stephen G. O’Brien and Marc S. Rudoltz and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Biochemistry.

In The Last Decade

Manisha Mone

29 papers receiving 2.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia

2009 627 citations Andreas Hochhaus, S G O'Brien et al. Leukemia profile →
International Randomized Study of Interferon Vs STI571 (IRIS) 8-Year Follow up: Sustained Survival and Low Risk for Progression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib.

2009 444 citations Stephen G. O’Brien, François Guilhot et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Manisha Mone United States	20	1.7k	1.4k	998	504	487	29	2.7k
Francis J. Giles United States	28	884 0.5×	408 0.3×	173 0.2×	772 1.5×	1.0k 2.1×	50	2.6k
Florian H. Heidel Germany	30	1.8k 1.1×	995 0.7×	261 0.3×	509 1.0×	1.7k 3.4×	143	3.1k
Takatoshi Koyama Japan	28	601 0.4×	176 0.1×	98 0.1×	283 0.6×	504 1.0×	92	2.0k
Nicolas Chapuis France	26	970 0.6×	363 0.3×	53 0.1×	466 0.9×	1.8k 3.6×	74	2.7k
Adriana Zingone United States	23	447 0.3×	105 0.1×	102 0.1×	430 0.9×	945 1.9×	59	1.8k
Gautam Shrikhande United States	24	363 0.2×	186 0.1×	111 0.1×	197 0.4×	787 1.6×	42	1.8k
Bruce Gerlitz United States	18	681 0.4×	176 0.1×	58 0.1×	70 0.1×	428 0.9×	29	1.8k
Merav Leiba Israel	23	929 0.6×	224 0.2×	98 0.1×	930 1.8×	824 1.7×	77	2.0k
Archana M. Agarwal United States	22	299 0.2×	386 0.3×	71 0.1×	495 1.0×	647 1.3×	104	1.6k
Bartosz Wasąg Poland	28	217 0.1×	122 0.1×	312 0.3×	399 0.8×	465 1.0×	93	2.7k

Countries citing papers authored by Manisha Mone

Since Specialization

Citations

This map shows the geographic impact of Manisha Mone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manisha Mone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manisha Mone more than expected).

Fields of papers citing papers by Manisha Mone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manisha Mone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manisha Mone. The network helps show where Manisha Mone may publish in the future.

Co-authorship network of co-authors of Manisha Mone

This figure shows the co-authorship network connecting the top 25 collaborators of Manisha Mone. A scholar is included among the top collaborators of Manisha Mone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manisha Mone. Manisha Mone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lear, John T., Michael R. Migden, Karl D. Lewis, et al.. (2017). Long‐term efficacy and safety of sonidegib in patients with locally advanced and metastatic basal cell carcinoma: 30‐month analysis of the randomized phase 2 BOLT study. Journal of the European Academy of Dermatology and Venereology. 32(3). 372–381. 137 indexed citations

Lear, John T., Ralf Gutzmer, Michael R. Migden, et al.. (2016). Investigator-assessed efficacy and safety of sonidegib in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma: results of the BOLT 30-month analysis. Melanoma Research. 1 indexed citations

Dummer, Reinhard, Michael R. Migden, Alexander Guminski, et al.. (2016). Efficacy and safety of sonidegib in patients (pts) with locally advanced (la) or metastatic (m) basal cell carcinoma (BCC): BOLT 30-month analysis.. Journal of Clinical Oncology. 34(15_suppl). 9538–9538. 2 indexed citations

Migden, Michael R., Alexander Guminski, Ralf Gutzmer, et al.. (2014). Randomized, double-blind study of sonidegib (LDE225) in patients (pts) with locally advanced (La) or metastatic (m) basal-cell carcinoma (BCC). Journal of Clinical Oncology. 32(15_suppl). 9009a–9009a. 11 indexed citations

Baccarani, Michele, Brian Druker, Susan Branford, et al.. (2014). Long-term response to imatinib is not affected by the initial dose in patients with Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: final update from the Tyrosine Kinase Inhibitor Optimization and Selectivity (TOPS) study. International Journal of Hematology. 99(5). 616–624. 32 indexed citations

Vasanthavada, Madhav, Yanfeng Wang, Thomas Haefele, et al.. (2010). Application of Melt Granulation Technology Using Twin-screw Extruder in Development of High-dose Modified-Release Tablet Formulation. Journal of Pharmaceutical Sciences. 100(5). 1923–1934. 49 indexed citations

Kantarjian, Hagop M., Richard A. Larson, François Guilhot, et al.. (2009). Efficacy of imatinib dose escalation in patients with chronic myeloid leukemia in chronic phase. Cancer. 115(3). 551–560. 86 indexed citations

Hochhaus, Andreas, S G O'Brien, François Guilhot, et al.. (2009). Six-year follow-up of patients receiving imatinib for the first-line treatment of chronic myeloid leukemia. Leukemia. 23(6). 1054–1061. 627 indexed citations breakdown →

Hughes, Timothy P., Andreas Hochhaus, Susan Branford, et al.. (2008). Reduction of BCR-ABL Transcript Levels at 6, 12, and 18 Months (mo) Correlates with Long-Term Outcomes on Imatinib (IM) at 72 Mo: An Analysis from the International Randomized Study of Interferon versus STI571 (IRIS) in Patients (pts) with Chronic Phase Chronic Myeloid Leukemia (CML-CP). Blood. 112(11). 334–334. 23 indexed citations

10.

Hochhaus, Andreas, Brian Druker, Charles L. Sawyers, et al.. (2007). Favorable long-term follow-up results over 6 years for response, survival, and safety with imatinib mesylate therapy in chronic-phase chronic myeloid leukemia after failure of interferon-α treatment. Blood. 111(3). 1039–1043. 160 indexed citations

11.

Kantarjian, Hagop M., Charles L. Sawyers, Andreas Hochhaus, et al.. (2006). Six Year Follow-Up Results of a Phase II Study of Imatinib in Late Chronic Phase (L-CP) Chronic Myeloid Leukemia (CML) Post Interferon-A (IFN) Refractoriness/Intolerance.. Blood. 108(11). 428–428. 4 indexed citations

12.

Burkey, B F, M Kellis, Leonardo Bolognese, et al.. (2005). Acute and Chronic Effects of the Incretin Enhancer Vildagliptin in Insulin-Resistant Rats. Journal of Pharmacology and Experimental Therapeutics. 315(2). 688–695. 95 indexed citations

13.

Valencia, Jessica, Manisha Mone, Jin Zhang, et al.. (2004). Divergent Pathways of Gene Expression Are Activated by the RAGE Ligands S100b and AGE-BSA. Diabetes. 53(3). 743–751. 72 indexed citations

14.

Mone, Manisha, et al.. (2004). Binding of receptor for advanced glycation end products (RAGE) ligands is not sufficient to induce inflammatory signals: lack of activity of endotoxin-free albumin-derived advanced glycation end products. Diabetologia. 47(5). 844–852. 74 indexed citations

15.

Villhauer, Edwin B., J. A. Brinkman, Beth E. Dunning, et al.. (2002). 1-[2-[(5-Cyanopyridin-2-yl)amino]ethylamino]acetyl-2-(S)-pyrrolidinecarbonitrile: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties. Journal of Medicinal Chemistry. 45(12). 2362–2365. 104 indexed citations

16.

Schoutens, André, et al.. (1990). Anaemia and marrow blood flow in the rat. British Journal of Haematology. 74(4). 514–518. 5 indexed citations

17.

Schoutens, André, M. Verhas, N Dourov, et al.. (1988). Bone loss and bone blood flow in paraplegic rats treated with calcitonin, diphosphonate, and indomethacin. Calcified Tissue International. 42(2). 136–143. 32 indexed citations

18.

Verhas, M., André Schoutens, Mireille L’Hermite‐Balériaux, et al.. (1986). The effect of orchidectomy on bone metabolism in aging rats. Calcified Tissue International. 39(2). 74–77. 53 indexed citations

19.

Schwarz, Steven M., et al.. (1985). Intestinal membrane lipid composition and fluidity during development in the rat. American Journal of Physiology-Gastrointestinal and Liver Physiology. 248(2). G200–G207. 60 indexed citations

20.

Kaplan, Jack H. & Manisha Mone. (1985). Modified cation activation of the (Na+K)-ATPase following treatment with thimerosal. Archives of Biochemistry and Biophysics. 237(2). 386–395. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact